|
Intrahepatic tumor size (cm)
| | |
0.539
| | |
0.045
|
|
Mean
|
2.0 ± 1.3
|
1.9 ± 1.3
| |
3.5 ± 3.3
|
2.6 ± 2.1
| |
|
Median
|
1.7 (1.3)
|
1.6 (1.0)
| |
2.5 (1.9)
|
2.1 (1.3)
| |
|
Recurrence number
| | |
0.394
| | |
0.383
|
|
1
|
44 (52.4)
|
86 (57.0)
| |
13 (27.1)
|
38 (32.2)
| |
|
2
|
12 (14.3)
|
21 (13.9)
| |
4 (8.3)
|
14 (11.9)
| |
|
3
|
4 (4.8)
|
5 (3.3)
| |
0
|
9 (7.6)
| |
|
> 3
|
20 (23.8)
|
29 (19.2)
| |
20 (41.7)
|
41 (34.7)
| |
|
Non-intrahepatic recurrence
|
4 (4.8)
|
10 (6.6)
| |
11 (22.9)
|
16 (13.6)
| |
|
Recurrence location
| | |
0.686
| | |
0.755
|
|
Intrahepatic recurrence
|
77 (91.7)
|
136 (90.1)
| |
33 (68.8)
|
84 (71.2)
| |
|
Distant metastasis
|
7 (8.3)
|
15 (9.9)
| |
15 (31.3)
|
34 (28.8)
| |
|
Lung
|
5 (6)
|
8 (5.3)
| |
12 (25.0)
|
27 (22.9)
| |
|
Bone
|
1 (1.2)
|
1 (0.7)
| |
0
|
1 (0.8)
| |
|
Others
|
1 (1.2)
|
6 (4.0)
| |
3 (6.3)
|
6 (5.1)
| |
|
Recurrence BCLC stage (A, B and C)
| | |
0.580
| | |
0.280
|
|
A
|
53 (63.1)
|
103 (68.2)
| |
15 (31.3)
|
49 (41.5)
| |
|
B
|
22 (26.2)
|
28 (18.5)
| |
15 (31.3)
|
31 (26.3)
| |
|
C
|
9 (10.7)
|
20 (13.2)
| |
18 (37.5)
|
38 (32.2)
| |
|
Curative intent treatment for recurrence
| | |
0.430
| | |
0.388
|
|
Yes
|
29 (34.5)
|
60 (39.7)
| |
7 (14.6)
|
24 (20.3)
| |
|
No
|
55 (65.5)
|
91 (60.3)
| |
41 (85.4)
|
94 (79.7)
| |
|
Total treatment for recurrence (times)
|
|
Resection
|
15
|
23
| |
9
|
14
| |
|
Ablation
|
38
|
124
| |
23
|
76
| |
|
LT
|
1
|
1
| |
0
|
0
| |
|
TACE
|
62
|
134
| |
26
|
114
| |
|
Radiotherapy
|
4
|
4
| |
1
|
9
| |
